Lv3
282 积分 2021-03-05 加入
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells
7天前
已完结
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
2个月前
已完结
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
2个月前
已完结
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
2个月前
已完结
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
2个月前
已完结
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2个月前
已完结
Recent update on the development of EZH2 inhibitors and degraders for cancer therapy
2个月前
已完结
An updated patent review of EZH2 inhibitors (2024–present)
2个月前
已完结
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth
3个月前
已完结
Overview of BH3 mimetics in ovarian cancer
3个月前
已完结
皖公网安备34019202002308
